Medite Cancer Diagnostics Inc (MDIT) 0.4800 $MDIT MEDITE

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Medite Cancer Diagnostics Inc (MDIT) 0.4800 $MDIT

MEDITE Receives China FDA Approval for "SureThin" Preservative Solution
ACCESSWIRE - Mon Jun 13, 1:45PM CDT
ORLANDO, FL / ACCESSWIRE / June 13, 2016 / MEDITE Cancer Diagnostics, Inc., (OTCQB: MDIT, the "Company" specializing in the development, manufacturing, and marketing of molecular biomarkers and premium medical devices for detection, risk assessment and diagnosis of cancer and precancerous conditions announces that UNIC Medical, the Company's Chinese distribution partner received May 31, 2016 China FDA approval as a Class I in vitro diagnostic reagent for MEDITE's "SureThin" cell preservation solution.

MEDITE Cancer Diagnostics, Inc. Reports $9.9 Million in Revenue and Results for 2015
ACCESSWIRE - Wed Apr 13, 8:00AM CDT
ORLANDO, FL / ACCESSWIRE / April 13, 2016 / MEDITE Cancer Diagnostics, Inc., (OTCQB: MDIT, the "Company" specializing in the development, manufacturing, and marketing of molecular biomarkers and premium medical devices for detection, risk assessment and diagnosis of cancer and precancerous conditions announces its 2015 financial results.

MEDITE Cancer Diagnostics, Inc. will present at the SeeThruEquity Healthcare Investor Conference on January 11
PR Newswire - Thu Jan 07, 2:19PM CST
MEDITE Cancer Diagnostics, Inc. (OTC:MDIT, the "Company", specializing in the development, manufacturing, and marketing of molecular biomarkers and premium medical devices for detection, risk assessment and diagnosis of cancer and precancerous conditions, announces today that CEO, Michaela Ott and CFO, Robert McCullough will present at the SeeThruEquity First Annual Microcap Healthcare Investor Conference on Monday, January 11, 2016, at the Fairmont San Francisco in San Francisco, Calif.

MEDITE Cancer Diagnostics, Inc. Reports a Profitable Third Quarter and Nine Month 2015 Results
PR Newswire - Tue Nov 17, 8:00AM CST
MEDITE Cancer Diagnostics, Inc., (OTCQB:MDIT, the "Company" specializing in the development, manufacturing, and marketing of molecular biomarkers and premium medical devices for detection, risk assessment and diagnosis of cancer and precancerous conditions, announces its third quarter and nine month 2015 results.

Investment by UNIC Technologies CEO Dr. Zhongxi Zheng for 5.06% of MEDITE Cancer Diagnostics, Inc. Highlights Digital Cancer Diagnostic Strategy
BusinessWire - Wed Sep 09, 8:18AM CDT
MEDITE Cancer Diagnostics, Inc., (OTCQB: MDIT) specializing in the development, manufacturing, and marketing of immuno-assays and premium medical devices for detection, risk assessment and diagnosis of cancer and precancerous conditions, announces an investment by UNIC Medical, Inc.'s Chairman and UNIC Technologies, Inc.'s CEO, Dr. Zhongxi Zheng, an MD in Pathology. His investment represents 5.06% of MEDITE's outstanding common shares after the investment. In exchange for Dr. Zheng's $1.738 million investment, MEDITE Cancer Diagnostics, Inc. issued 1,086,250 shares of unregistered common stock at the per share price of $1.60. These shares are exempt from registration under Regulation S of the Securities Act of 1933.

MEDITE Cancer Diagnostics, Inc. Announces Change of Auditor
PR Newswire - Thu May 14, 6:07PM CDT
MEDITE Cancer Diagnostics, Inc., ("Company," OTCQB symbol: "MDIT" specializing in the development, manufacturing and marketing of molecular biomarkers and premium medical devices for detection, risk assessment and diagnosis of cancer and precancerous conditions, announces change of auditors.

MEDITE Cancer Diagnostics, Inc. Announces short Delay for 10k Filing of 2014 Financials
PR Newswire - Thu Apr 16, 6:00AM CDT
MEDITE Cancer Diagnostics, Inc. (OTCQB: MDIT), specializing in the development, manufacturing and marketing of superior molecular biomarkers and premium medical devices and consumables for detection, risk assessment and diagnosis of cancer and related diseases announces a delay in the filing of the Form - 10k with the Securities and Exchange Commission.

MEDITE Cancer Diagnostics, Inc. Announces Granted Patent "Lab-in-One Automation" System
PR Newswire - Fri Mar 20, 11:59AM CDT
MEDITE Cancer Diagnostics, Inc., (MDIT) specializing in the development, manufacturing and marketing of superior molecular biomarkers and premium medical devices for detection, risk assessment and diagnosis of cancer and related diseases announced the recent decision of the German Patent Register to grant MEDITE the German priority patent for its Histology "Lab-in-one Automation" System. Based on this success MEDITE will finish its nationalization applications for USA, China and UK before April 4th, 2015.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ractigen's Breakthrough in DMD: RNA Activates Utrophin

Updated Category News Views 3

Ractigen's New Fight Against Duchenne: A Personal Take When it comes to biotech advancements, I've seen enough breakthroughs to not get swayed easily. But Ractigen Therapeutics presenting their first-in-human data on RNA activation for Duchenne Muscular Dystrophy (DMD) kind of demands your attention. Folks, they're talking about a potential shift in handling this brutal...

Continue Reading
Vatrer Power: Lithium Batteries Revolutionize Golf Carts

Updated Category News Views 2

The humdrum world of golf carts just got a jolt of energy with lithium batteries entering the fray. Vatrer Power, the brain behind some nifty LiFePO4 lithium battery conversions, made some noise at this year's Golf Carting Expo & Dealer Summit in Charleston, South Carolina. Held at the North Charleston Convention Center, this trade show was the industry's premier...

Continue Reading
Kal Plastics Showcases at Design-2-Part Expo

Updated Category News Views 3

Kal Plastics Steps into the Limelight There's a buzz in the air, and it's all about Kal Plastics getting ready to strut their stuff at the Southern California Design-2-Part Show. Now, most folks probably don't spend their nights dreaming about thermoforming and pressure forming, but these guys sure make a case for it. They’ve got their eyes on impressing the crowd with...

Continue Reading
Venice's Climate Challenge: Rising Seas, Sinking Lands

Updated Category News Views 3

Sea Rise Isn’t Just a Statistics Problem The ordeal of rising seas isn't just about staring at numbers in some spreadsheet, it's a real-world gut punch that's knocking at Venice's door. This city, known for its stunning architecture and winding canals, now serves as the poster child for what happens when Mother Nature and human errors leave a place on the brink of...

Continue Reading
Honeywell's Supply Line Snags Bait Class Action Risk

Updated Category News Views 8

Stepping into the chaos of the stock market sometimes feels like opening Pandora's box—just when you think you've seen it all, something new tumbles out. This time around, it's Honeywell Aerospace (NasdaqGS: HONA) playing catch with hot coals, and a burning class-action lawsuit smolders in the air. Deadline Looms for Investors in Class Action Heads up, folks! If you've...

Continue Reading
Trading Platforms Poised for Billions by 2031

Updated Category News Views 4

Forecasts and Fierce Digital Landscapes Just when you thought the online trading realm was getting saturated, the numbers are making it clear: there’s still room for growth—even explosive growth. The online trading platform market is eyeing a hike, jumping from a $11.65 billion valuation in 2025 to a projected $18.18 billion by 2031, according to Mordor Intelligence....

Continue Reading
Govee Stirs Halloween Chills with New Sarah Gellar Ad

Updated Category News Views 4

Lighting Up Halloween the Hollywood Way When it comes to Halloween, folks go nuts driving up the thrill factor at home, and boy, has Govee nailed it this time around. They've dragged Sarah Michelle Gellar into their spooky mix, transforming homes into eerie masterpieces. And let's face it, who better than the 'Buffy the Vampire Slayer' herself to stir those spine-tingling...

Continue Reading
The Real Cost of Cabinet Decisions: Refinish or Replace?

Updated Category News Views 3

Uncovering the Truth Behind Cabinet Decisions When it comes to sprucing up a kitchen, most folks overlook what's hanging on their walls already: those tired old cabinets. Now, are you looking at chucking them out the window for brand-new ones, or can a fresh coat of paint breathe new life into them? Well, that's where Melvin Jones, a painting virtuoso from Lexington,...

Continue Reading
Aetna's 2027 Medicare Plans: Comprehensive Outlook

Updated Category News Views 3

Unpacking Aetna's Medicare Strategy for 2027 Look, if there's one thing you should keep tabs on, it's how Aetna isn't just coasting by in the healthcare arena. These folks are pushing forward with new options for 2027 that prove they're serious about making healthcare not just accessible, but affordable across the board. Aetna, backed by CVS Health (NYSE: CVS), is making...

Continue Reading

Top 5 Most Recently Viewed Articles

Explore GOTS' #BehindTheSeams Campaign for Sustainability

Updated Category News Views 273

#BehindTheSeams Campaign Highlights Sustainable Textiles The Global Organic Textile Standard (GOTS) is excited to bring back its engaging #BehindTheSeams campaign, inviting consumers to explore the sustainable practices behind GOTS-certified products. This year, the campaign runs throughout September, aiming to illuminate the vital role that sustainable textiles play in...

Continue Reading
Celebrating Osteopathic Medicine Month Across the Nation

Updated Category News Views 130

Understanding Osteopathic Medicine Month Each December, the contributions of osteopathic medicine are highlighted and celebrated across various states and cities. This year, over 20 states are recognizing this month as Osteopathic Medicine Month, showcasing the incredible impact of nearly 200,000 osteopathic physicians (DOs) and medical students in the healthcare...

Continue Reading
Huffman Family Foundation's $2M Impact on Maryland Education

Updated Category News Views 9

A Bold Step: Huffman Family's Generous Pledge When someone throws over $2 million behind the future of education, you're bound to feel some ripples. That's exactly the move Huffman Family Foundation just made. They're on a mission to uplift Maryland’s schools and community programs while tackling education challenges head-on. Investments Geared Towards Transformation...

Continue Reading
Analyzing Crypto Trends: Bitcoin, Ethereum, and Solana's Future

Updated Category News Views 107

Can Bitcoin Challenge Market Sentiment This September? As Bitcoin continues to hold its ground above the $110,000 mark, discussions in the crypto community are intensifying. The debate centers on whether its current price action signals a potential reverse or if further declines are on the horizon. Many market analysts observe this situation closely, looking for signs...

Continue Reading
Discover the Future of Mining with XRP's New App Launch

Updated Category News Views 134

XRP Mining Revolutionizes Cryptocurrency Access In today's fast-paced digital financial landscape, cryptocurrencies are becoming a prominent aspect of investment strategies. For many prospective investors, traditional cryptocurrency mining presents various hurdles including costly equipment, technical know-how, and constant management of complex systems. Fortunately, the...

Continue Reading